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Summary
The age-dependent decline in the self-renewal capacity of stem
cells plays a critical role in aging, but the precise mechanisms
underlying this decline are not well understood. By limiting
proliferative capacity, senescence is thought to play an important
role in age-dependent decline of stem cell self-renewal, although
direct evidence supporting this hypothesis is largely lacking. We
have previously identified the E3 ubiquitin ligase Smurf2 as a
critical regulator of senescence. In this study, we found that mice
deficient in Smurf2 had an expanded hematopoietic stem cell
(HSC) compartment in bone marrow under normal homeostatic
conditions, and this expansion was associated with enhanced
proliferation and reduced quiescence of HSCs. Surprisingly,
increased cycling and reduced quiescence of HSCs in Smurf2-
deficient mice did not lead to premature exhaustion of stem cells.
Instead, HSCs in aged Smurf2-deficient mice had a significantly
better repopulating capacity than aged wild-type HSCs, suggest-
ing that decline in HSC function with age is Smurf2 dependent.
Furthermore, Smurf2-deficient HSCs exhibited elevated long-term
self-renewal capacity and diminished exhaustion in serial trans-
plantation. As we found that the expression of Smurf2 was
increased with age and in response to regenerative stress during
serial transplantation, our findings suggest that Smurf2 plays an
important role in regulating HSC self-renewal and aging.
Key words: aging; hematopoietic stem cells; self-renewal;
senescence; Smurf2.
Introduction
Aging is a complex process of gradual deterioration of physiological
functions that involves virtually all cells and tissues. Tissue-specific stem
cells, which are capable of self-renewal to preserve stem cell pools as
well as differentiation into a variety of effector cells, play a central role in
the normal homeostatic maintenance and regenerative repair of tissues
throughout the lifetime of an organism. With advancing age, the self-
renewal capacity of stem cells invariably declines, eventually leading to
the accumulation of unrepaired, damaged tissues in old organisms
(Rando, 2006; Sharpless & DePinho, 2007; Rossi et al., 2008). Aging of
the hematopoietic system is driven by many intrinsic and extrinsic factors
that adversely affect the production and functions of blood cells (Van
Zant & Liang, 2003; Chambers & Goodell, 2007; Rossi et al., 2008).
Increasing evidence suggests that attenuated hematopoietic stem cell
(HSC) function plays an important role in hematopoietic aging, including
anemia, decreased immune function, and increased propensity for
myeloid malignancies. The ability of HSCs to repopulate and reconstitute
lethally irradiated recipients is limited in serial transplantation, reflecting
a finite potential of HSC self-renewal under regenerative stress (Ogden &
Mickliem, 1976; Harrison & Astle, 1982). In aged mice, HSCs undergo
distinct changes: They exhibit decreased repopulating ability, even
though the number of phenotypic HSCs based on staining of cell surface
markers increases with age in some laboratory mouse strains. Further,
aged HSCs show a differentiation preference toward myeloid lineages at
the expense of lymphoid differentiation (Morrison et al., 1996; Sudo
et al., 2000; Liang et al., 2005; Rossi et al., 2005; Chambers et al.,
2007). In humans, aged HSCs also show increased frequency and a bias
toward myeloid potential (Pang et al., 2011).
The molecular mechanisms responsible for age-dependent decline in
HSC self-renewal are complex and many factors have been implicated
(Van Zant & Liang, 2003; Chambers & Goodell, 2007; Rossi et al., 2008).
Senescence, a state of irreversible growth arrest that most cells enter at
the end of their replicative lifespan, has been proposed to contribute to
aging by reducing the renewal capacity of stem cells (Sharpless &
DePinho, 2004; Campisi, 2005). Although direct evidence supporting the
senescence theory of aging is lacking, several senescence regulators
including p16INK4a (p16) and p53 have been found to play important
roles in aging. The expression of p16 increases with age in many human
and rodent tissues (Krishnamurthy et al., 2004; Ressler et al., 2006).
Age-associated increase in p16 in mice coincides with a decline in the
renewal capacity of stem cells in bone marrow, brain, and pancreas
(Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006),
although p16 up-regulation in aged HSCs has been challenged (Attema
et al., 2009). HSCs in old mice lacking p16 have increased regenerative
potential, suggesting that p16 plays a critical role in limiting HSC self-
renewal (Janzen et al., 2006). In p53-null mice, the number of HSCs
increases and they perform better in competitive repopulation, suggest-
ing an enhanced self-renewal capacity (TeKippe et al., 2003; Liu et al.,
2009). Moreover, mice with one wild-type allele and one mutant allele of
p53 that lacks the N-terminal transactivation domain maintain cancer
protection, but age prematurely including impairment of HSCs (Tyner
et al., 2002; Maier et al., 2004; Dumble et al., 2007). These studies
support an emerging link between senescence regulation and aging and
show the potential importance of senescence regulation in the aging of
HSCs.
We have recently shown that the E3 ubiquitin ligase Smurf2 plays a
critical role in regulating the senescence response in human and mouse
cells (Zhang & Cohen, 2004; Kong et al., 2011; Ramkumar et al., 2012).
Adventitious expression of Smurf2 is sufficient to induce senescence in
early passage cells (Zhang & Cohen, 2004; Ramkumar et al., 2012),
while deficiency in Smurf2 expression impairs the senescence response in
culture and in vivo (Kong et al., 2011; Ramkumar et al., 2012). In this
study, we found that Smurf2 deficiency led to increased proliferation
and an expanded HSC compartment in bone marrow. Surprisingly,
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increased proliferation did not lead to early HSC exhaustion. Instead,
Smurf2-deficient HSCs showed better repopulating ability and multilin-
eage potential than wild-type cells with advancing age or under
regenerative stress, suggesting a functional role of Smurf2 in the
regulation of HSC self-renewal and aging.
Results
Increased expression of Smurf2 in mouse bone marrow
during aging
We have shown previously that Smurf2 is an important regulator of
senescence (Zhang & Cohen, 2004; Kong et al., 2011; Ramkumar et al.,
2012). To investigate whether Smurf2 plays a role in aging, we first
examined the expression of Smurf2 in mouse bone marrow (BM) and the
LSK (LinSca-1+c-kit++; Lin: negative for lineage markers B220, CD3,
CD11b, CD19, Gr-1, and Ter-119) population that is enriched for HSCs
(Ikuta & Weissman, 1992; Okada et al., 1992; Osawa et al., 1996). We
found that Smurf2 expression was increased in total BM and LSK cells of
aged (24-month) C57BL/6 mice compared with young (2-month) mice
(Fig. 1).
We have generated a Smurf2-deficient mouse model (Smurf2T/T, T for
the trapped allele), in which a gene-trapping cassette is inserted into
intron 1 of Smurf2 to disrupt its normal splicing (Ramkumar et al.,
2012). The expression of Smurf2 was significantly reduced in total BM
and LSK cells of Smurf2-deficient mice compared with wild-type (WT)
mice (Fig. 1). Because of the hypomorphic nature of the trapped Smurf2
allele, there were residual normal splicing and Smurf2 expression in BM,
LSK cells (Fig. 1), common lymphoid progenitors, multipotent progen-
itors, and HSCs (Fig. S1A) of Smurf2-deficient mice, similar to what we
have found previously in other tissues (Ramkumar et al., 2012). Reduced
Smurf2 expression in this mouse model allowed us to investigate
whether Smurf2 has a functional role in HSC aging.
Expansion of long-term HSCs in Smurf2-deficient mice
To investigate the role of Smurf2 in HSC aging, we used flow
cytometry to enumerate BM populations enriched for long-term HSCs
(LT-HSCs) (LinSca1+c-kit++CD150+Flt3), short-term HSCs (ST-HSCs:
LinSca1+c-kit++CD150Flt3), and multipotent progenitors (MPPs:
LinSca1+c-kit++CD150Flt3+) (Adolfsson et al., 2001; Wilson et al.,
2007; Papathanasiou et al., 2009) (Fig. 2A). We noticed a statistically
significant increase (1.28-fold, P = 0.026) in the total live BM cells
collected from long bones of hind and forelegs of 2-month-old
Smurf2-deficient mice compared with age-matched WT mice (Fig. 2B),
whereas gross body weights were not significantly different between
WT and Smurf2-deficient mice (Fig. S1B). Although no significant
difference in the frequencies of LT-HSCs, ST-HSCs, MPPs, or LSK
population was found between young WT and Smurf2-deficient mice
(Fig. 2C), the total number of LT-HSCs in young Smurf2-deficient mice
was significantly increased (1.64-fold, P = 0.038) compared with WT
mice (Fig. 2D). ST-HSCs, MPPs, or LSK cells were also increased
(1.30–1.45-fold) in young Smurf2-deficient mice, although the
increases were not statistically significant (Fig. S2A).
In aged (24- to 30-month) mice, we also found an increase in BM
cellularity in Smurf2-deficient mice (1.59-fold, P = 0.0007) compared
with WT mice (Fig. 2B). Similar to what we found in young mice, the
frequencies of LT-HSCs, ST-HSCs, MPPs, and LSK population were not
significantly different between aged WT and Smurf2-deficient mice
(Fig. 2E). Although the average numbers of LT-HSCs, ST-HSCs, MPPs,
and LSK populations increased (1.73–2.21-fold) in aged Smurf2-deficient
mice, there were great variations among individual aged mice and the
increases were not significantly different from those in WT mice (Fig. 2
and Fig. S2B).
Complete blood count analyses of peripheral blood showed no
significant difference between age-matched WT and Smurf2-deficient
mice at either young (2 months) or old (18–20 months) age in various
lineages, including white blood cells, red blood cells, lymphocytes,
granulocytes, monocytes, and platelets (Fig. S3). These results suggest
that differentiation and commitment of HSCs to various lineages are not
affected by Smurf2 deficiency.
Enhanced cell proliferation of LT-HSCs in Smurf2-deficient
mice
The observed increases in BM cells and LT-HSCs in Smurf2-deficient mice
suggest an enhanced cell proliferation of these cells. Supporting this
notion, we found that the fraction of BM cells in the S phase of cell cycle
was increased in 2-month-old Smurf2-deficient mice compared with WT
mice (Fig. S4A; 11.9  0.7% in Smurf2-deficient vs. 8.1  0.4% in WT,
P = 0.0012). To further investigate whether cell proliferation is enhanced
in Smurf2-deficient LT-HSCs and progenitor populations, we gave young
mice 4 injections of bromodeoxyuridine (BrdU) in a span of 24 h to label
LT-HSCs (Passegue et al., 2005). BrdU was incorporated in a significant
portion of LT-HSCs (LinSca1+c-kit++CD150+) using this labeling method
(Fig. 3). We found that BrdU incorporation was significantly increased in
Smurf2-deficient LT-HSCs (1.8-fold, P = 0.019) compared with WT LT-
HSCs (Fig. 3). Increased BrdU incorporation was also observed in Smurf2-
deficient LSK and ST-HSC/MPP (LinSca1+c-kit++CD150) populations
compared with WT cells (Fig. S4B).
As most LT-HSCs in adult mice remain quiescent (Cheshier et al.,
1999), we combined Ki-67 staining with cell cycle analysis to determine
the frequencies of LT-HSCs that are quiescent or cycling (Fig. 3). Smurf2-
deficient LT-HSCs (LinSca1+c-kit++CD150+) exhibited decreased
frequency in the G0 phase (54.2% in Smurf2-deficient vs. 71.2% in
WT; P = 0.014), and increased frequencies in the G1 (33.8% in
Smurf2-deficient vs. 22.1% in WT; P = 0.013) and S-G2/M phases
(11.8% in Smurf2-deficient vs. 5.1% in WT; P = 0.005) (Fig. 3).
Similarly, Smurf2-deficient LSK and ST-HSC/MPP (LinSca1+c-
kit++CD150) populations also showed significantly increased cycling
and decreased quiescence (Fig. S4C). We did not observe LT-HSCs in
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Fig. 1 Increased Smurf2 expression in aged mice. Quantitative RT–PCR analysis of
Smurf2 expression in bone marrow (BM) and sorted LSK (LinSca1+c-kit++) cells of
young (2-month) and old (24-month) wild-type (+/+) and Smurf2T/T (T/T) mice.
Relative expression in young wild-type cells was set to be 1 after normalization
with b-actin. Error bars are SD of three independent experiments. Student’s t-test
is used for statistical analysis. **P < 0.01, ***P < 0.001.
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sub-G1 phase, suggesting that there is no apoptosis in these cells.
Collectively, these data indicate that cell proliferation is enhanced in
Smurf2-deficient LT-HSCs.
Enhanced repopulation ability of HSCs in aged
Smurf2-deficient mice
As quiescence has been postulated to prevent premature stem cell
exhaustion during aging (Orford & Scadden, 2008), our observation of
decreased frequency of quiescent LT-HSCs in Smurf2-deficient mice
suggests that Smurf2-deficient HSCs may experience premature exhaus-
tion. To determine the self-renewal ability and multilineage potential of
HSCs, we used competitive repopulation (Harrison, 1980), in which
donor BM cells of either WT or Smurf2-deficient mice (CD45.2+) were
mixed at a 1:1 ratio with competitor BM cells of 2-month-old CD45.1+/
CD45.2+ WT mice and injected into lethally irradiated congenic recipient
mice (CD45.1+). Contribution of donor, competitor, and recipient in
peripheral blood and BM of reconstituted recipients was determined by
flow cytometry at different time post-transplantation. As we have found
previously that ~30% of Smurf2-deficient mice develop tumor sponta-
neously after 12 month of age, and ~70% of tumors are B-cell
lymphomas in spleen (Ramkumar et al., 2012), only mice that were
tumor free were used in this study. We selected aged mice that were
physically fit without any sign of stress or illness and did not have visible
tumors upon necropsy. Furthermore, we used flow cytometry to
characterize spleen from these aged mice to make sure that there was
no lymphoma as described (Ramkumar et al., 2013). Smurf2-deficient
HSCs of young (2-month) mice were more efficient in repopulating B
and myeloid cells than young WT HSCs and as efficient as WT HSCs in
repopulating T cells in the peripheral blood of the reconstituted recipient
mice (Fig. 4). Interestingly, Smurf2-deficient HSCs of aged (24-month)
animals showed significantly better repopulation ability than the age-
matched WT HSCs (Fig. 4), despite the decreased quiescence and
increased cycling of Smurf2-deficient LT-HSCs. In fact, old Smurf2-
deficient HSCs had similar repopulating ability as the young HSCs
(Fig. 4). Furthermore, analysis of BM and LSK population 6 months after
transplantation showed increased contribution from aged Smurf2-
deficient donor compared with WT donor (Fig. 4). Collectively, these
results indicate that HSCs in aged Smurf2-deficient mice have better
repopulation ability and suggest that Smurf2 deficiency protects HSCs
from early exhaustion during aging.
Smurf2-deficient LT-HSCs exhibit better long-term
self-renewal capacity under regenerative stress
To investigate the long-term self-renewal and multilineage potential of
HSCs, we used BM serial transplantation, in which LT-HSCs in donor BM
are able to reconstitute lethally irradiated recipients in successive but
limited transplantations, reflecting the finite potential of HSC self-
renewal (Ogden & Mickliem, 1976; Harrison & Astle, 1982). As the
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Fig. 2 Increased bone marrow (BM)
cellularity and expanded long-term
hematopoietic stem cell (LT-HSC)
population in Smurf2-deficient mice. (A)
Representative flow cytometry analysis of
HSCs in BM of 2-month-old wild-type (+/+)
and Smurf2T/T (T/T) mice. Live lineage-
negative (Lin-) cells are gated and displayed
for staining of Sca1 and c-Kit (left panels).
LSK (LinSca1+c-kit++) population is gated
and displayed for staining of CD150 and
Flt3 (right panels). LT-HSCs are defined
as LinSca1+c-kit++CD150+Flt3,
while LinSca1+c-kit++CD150Flt3 and
LinSca1+c-kit++CD150Flt3+ are used to
enumerate short-term HSCs (ST-HSCs) and
multipotent progenitors (MPPs),
respectively. (B) Average live BM cell
numbers in young (2-month, N = 16) and
old (24- to 30-month, N = 7) mice. (C)
Frequencies of LT-HSC, ST-HSCs, MPP, and
LSK cells as percent of live BM cells in young
(2-month-old, N = 11) mice. (D) Average
LT-HSC numbers in young (2-month,
N = 11) and old (24- to 30-month, N = 6)
mice. (E) Frequencies of LT-HSC, ST-HSCs,
MPP, and LSK cells as percent of live BM
cells in old (24- to 30-month, N = 6) mice.
Error bars are SD and Student’s t-test is
used for statistical analysis.
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frequency of LT-HSCs in Smurf2-deficient mice was not significantly
different from WT mice, we used the same number of BM cells from
2-month-old WT and Smurf2-deficient mice in transplantation. We used
either female or male donors in two independent experiments. During
the 1st, 2nd, or 3rd transplantation, 100% of recipient mice receiving
donor BM from WT or Smurf2-deficient mice survived. Recipient mice
from the 3rd transplantation were followed for a year and none of them
died during observation. Staining of BM cells in the recipient mice during
these successive transplantations revealed that >75% of the LT-HSC
population had been reconstituted by the donor (Fig. S5A). Three
months after transplantation, complete blood count analysis of periph-
eral blood of recipient mice showed that various blood cell lineages were
successfully reconstituted by both the WT and Smurf2-deficient donors
(Fig. S5B).
During the 4th transplantation, all recipients receiving BM from WT
mice died within 3 weeks post-transplantation. In contrast, recipients
receiving BM from Smurf2-deficient mice showed significantly better
survival (Fig. 5; 63–67% survival, P < 0.001), suggesting that Smurf2-
deficient HSCs have an enhanced long-term self-renewal capacity. None
of these recipient mice died during 1 year of observation. We carried out
a 5th transplantation with Smurf2-deficient donors and found that 60%
of the recipient mice survived for 1 year post-transplantation without
signs of illness or stress (Fig. S6).
Similarly, we carried out BM serial transplantation using aged mice as
donors. All recipients receiving donor BM from either aged WT or
Smurf2-deficient mice survived during the first 3 cycles of transplanta-
tion. Complete blood count analysis of recipient peripheral blood
3 months after transplantation showed that various blood cell lineages
were successfully reconstituted by both the WT and Smurf2-deficient
donors (Fig. S5C). During the 4th transplantation, all recipients receiving
BM from WT mice died within 3 weeks post-transplantation, while
100% recipients receiving BM from Smurf2-deficient mice survived more
than 6 months post-transplantation (Fig. 5; P < 0.0001). Collectively,
these results indicate that Smurf2-deficient LT-HSCs have a better
capacity in the long-term self-renewal and multilineage potential than
the WT LT-HSCs. Furthermore, this stem cell-intrinsic functional
enhancement is maintained in aged Smurf2-deficient mice.
Smurf2 regulates p16 expression during aging and under
regenerative stress
Enhanced long-term self-renewal of Smurf2-deficient HSCs despite
increased cycling and decreased quiescence in these cells prompted us to
examine the expression of cyclin-dependent kinase inhibitors, as several
of them have been found to regulate HSC self-renewal. HSCs lacking
p18INK4c (p18) have increased self-renewal ability accompanied by
increased cycling (Yuan et al., 2004), and p16 has been shown to limit
HSC self-renewal during aging (Janzen et al., 2006). We found that p18
expression was not changed, while the expression of p16 and p19Arf
(p19), which are located in the same INK4a locus, was increased in BM of
aged (24-month) WT C57BL/6 mice compared with young (2-month)
mice (Fig. 6), consistent with a previous report (Krishnamurthy et al.,
2004). Interestingly, the expression of p16 and p18 was increased in LSK
cells with age, whereas p19 expression was undetectable in LSK cells
(Fig. 6). As our recent studies show that Smurf2 regulates the expression
of p16 during senescence (Kong et al., 2011), we found that p16
expression was significantly suppressed in BM and LSK cells in Smurf2-
deficient mice (Fig. 6). In contrast, the expression of p19 showed a slight
decrease and p18 was largely unchanged in Smurf2-deficient cells
(Fig. 6).
We then analyzed the expression of these genes as well as Smurf2 in
BM of reconstituted recipients during BM serial transplantation. We
found that Smurf2 expression was increased during successive trans-
plantation in mice receiving WT donor BM, concomitant with an increase
in the expression of p16, p18, or p19 (Fig. 6). While the increase in p18
and p19 expression was not consistently affected by Smurf2 deficiency,
the increase in p16 expression was greatly attenuated in mice receiving
the Smurf2-deficient donor BM (Fig. 6), suggesting a possible link
between p16 and Smurf2-mediated regulation of HSC self-renewal and
aging.
Discussion
An important characteristic of HSCs in adult animals is their relative
quiescence (Cheshier et al., 1999; Mahmud et al., 2001). It is thought
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that quiescence prevents premature stem cell exhaustion during aging
(Orford & Scadden, 2008). Many quiescence regulators have been found
to control stem cell aging. For example, cyclin-dependent kinase
inhibitor 1A (CDKN1A or p21) is required to maintain quiescence of
HSCs. In the absence of p21, increased cell cycling leads to premature
exhaustion and impaired self-renewal of HSCs (Cheng et al., 2000).
Conversely, deletion of transcriptional factor ELF4, a negative regulator
of quiescence, leads to increased quiescence and reduced exhaustion of
HSCs (Lacorazza et al., 2006). In this study, we found that Smurf2
deficiency led to enhanced cell proliferation in BM. HSCs in Smurf2-
deficient mice exhibited increased cell cycling and decreased quiescence.
Surprisingly, increased proliferation of HSCs in Smurf2-deficient mice did
not lead to premature stem cell exhaustion. Instead, Smurf2-deficient
HSCs showed increased long-term self-renewal and multilineage repop-
ulating capacity under regenerative stress in serial transplantation
compared with WT HSCs. Furthermore, HSCs in aged Smurf2-deficient
mice displayed better repopulating capability than HSCs in aged WT
mice. Taken together, our results indicate that Smurf2 deficiency
mitigates age-dependent decline in HSC self-renewal and function
despite increased HSC cycling.
We found that Smurf2 expression was increased in BM and LSK
population enriched for HSCs with advancing age or in response to
regenerative stress in serial transplantation, concomitant with increases
in the expression of p16, p19, and p18. HSCs lacking p18 have increased
long-term self-renewal capacity, even though these cells show increased
proliferation (Yuan et al., 2004). Our finding that p18 expression was
unchanged by Smurf2 deficiency suggests that p18 is unlikely respon-
sible for Smurf2-regulated decline in HSC self-renewal with age. It is
documented that p16 expression increases with age in many human and
rodent tissues, including BM and HSCs (Krishnamurthy et al., 2004;
Janzen et al., 2006; Ressler et al., 2006), although age-dependent
increase in p16 in HSCs has been challenged (Attema et al., 2009). In old
mice, p16/ HSCs perform much better than their WT counterparts in
serial transplantation, suggesting that age-dependent increase in p16
expression limits HSC self-renewal (Janzen et al., 2006). We have
recently found that Smurf2 regulates p16 expression during senescence
(Kong et al., 2011). In Smurf2-deficient mice, age or regenerative stress-
induced p16 expression was significantly attenuated, suggesting a
possible link between HSC self-renewal and p16 expression regulated by
Smurf2. Supporting this notion, we found that Smurf2-deficient HSCs of
aged mice substantially outperformed aged WT HSCs in competitive
repopulation and serial transplantation. In fact, old Smurf2-deficient
HSCs performed as well as young HSCs, a phenotype similarly observed
in old p16/ HSCs (Janzen et al., 2006). However, Smurf2-deficient
HSCs in young mice behaved differently from young p16/ HSCs,
which are more readily depleted in serial transplantation than WT HSCs
(Janzen et al., 2006). In contrast, HSCs in young Smurf2-deficient mice
also outperformed WT HSCs in serial transplantation and competitive
repopulation. It is possible that Smurf2 limits HSC self-renewal in a p16-
dependent manner only in aged mice, or Smurf2 deficiency protects age-
dependent decline in HSC self-renewal independently of p16. Additional
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Smurf2T/T (T/T) mice (CD45.2+) mixed at 1:1 ratio with competitor BM of 2-month-
old wild-type (CD45.1+/CD45.2+) mice are injected into lethally irradiated recipient
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studies are needed to address the precise role of p16 in Smurf2-
mediated regulation of HSC self-renewal and aging.
In complex organisms such as mammals, many somatic tissues such as
bone marrow are capable of renewal, repair, and even regeneration.
Renewable tissues allow the replacement of damaged cells, offering a
clear advantage over postmitotic tissues. It is important for stem cells to
maintain lifetime self-renewal and proliferation. In this study, we found
that Smurf2 expression was increased with advancing age in BM and LSK
cells. More importantly, HSCs in old Smurf2-deficient mice maintain their
self-renewal capacity at the level similar to young HSCs, suggesting that
functional decline in HSC self-renewal during aging is Smurf2
dependent. We have previously shown that Smurf2 is an important
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p16 expression is attenuated in Smurf2-
deficient mice. (A) Quantitative RT–PCR
analysis of gene expression in bone marrow
(BM) and sorted LSK (LinSca1+c-kit++) cells
of young (2-month) and old (24-month)
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*P < 0.05, **P < 0.01, ***P < 0.001, ns:
not significant.
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regulator of senescence (Zhang & Cohen, 2004; Kong et al., 2011;
Ramkumar et al., 2012). Increased expression of Smurf2 is sufficient to
induce senescence (Zhang & Cohen, 2004; Ramkumar et al., 2012),
while loss of Smurf2 expression impairs the senescence response in
culture and in vivo (Kong et al., 2011; Ramkumar et al., 2012).
Senescence is proposed to contribute to aging by depleting the renewal
capacity of tissues and/or by interfering with tissue homeostasis and
functions (Sharpless & DePinho, 2004; Campisi, 2005). Although cells
with characteristics of senescence have been detected to accumulate
with age in vivo, their functional contribution to aging is still not
completely clear (Sharpless & DePinho, 2004; Campisi, 2005). Our study
provides evidence for Smurf2 in regulating HSC self-renewal and aging,
further strengthening the emerging link between senescence and stem
cell aging.
Experimental procedures
Smurf2-deficient mice
Smurf2-deficient mice as described previously (Ramkumar et al., 2012)
had been backcrossed to C57BL/6 (CD45.2+) for more than 10
generations. All mouse studies were carried out according to guidelines
approved by the Institutional Animal Care and Use Committee of
University of Massachusetts Medical School.
Complete blood count
Peripheral blood was bled from mouse tail veins into EDTA-coated tubes,
and complete blood count analysis was performed using the Heska CBC-
Diff Veterinary Hematology System (Heska, Loveland, CO, USA).
Flow cytometry
Bone marrow cells were harvested from long leg bones and
resuspended in staining medium consisting of biotin-, flavin-, and
phenol red-deficient RPMI 1640 medium (Invitrogen, Carlsbad, CA,
USA) supplemented with 2% FBS (Hyclone, Logan, UT, USA), 10 mM
HEPES (pH 7.2), 1 mM EDTA, and 0.02% sodium azide. After filtering
through 70-lm nylon mesh, BM cells were incubated with anti-CD16/32
antibody (BioXCell, West Lebanon, NH, USA) for 10 min on ice to block
Fc receptors and then incubated with primary antibodies for 20 min.
The lineage cocktail contained biotin-conjugated antibodies to B220
(RA3-6B2), CD3e (145-2C11), CD11b (M1/70), CD19 (1D3), Ly-6G
(RB6-8C5), and Ter-119 (TER-119). Additional antibodies for HSC
analysis were Ly-6A/E(Sca1)-FITC or Ly-6A/E(Sca1)-PerCp-Cy5.5 (D7),
CD117(c-Kit)-PE-Cy7 or CD117(c-Kit)-APC (2B8), CD135(Flt3)-PE
(A2F10), and CD150-APC (mShad150). All antibodies were purchased
from eBioscience (San Diego, CA, USA). Cells stained with biotin-labeled
antibodies were incubated with streptavidin-eFluor 450 (eBioscience) for
15 min on ice and washed three times with staining medium. After the
final wash, cells were resuspended in staining medium with 1 lg mL-1
propidium iodide to exclude dead cells. Flow cytometry analysis was
performed on a 5-laser, 18-detector LSR II FACS (BD Biosciences, San
Jose, CA, USA), and data were analyzed using FlowJo software
(Treestar, Ashland, OR, USA).
Cell cycle and cell proliferation analyses
Mice were injected with 1 mg BrdU intraperitoneally every 6 h for
24 h as described previously (Passegue et al., 2005). BM cells were
stained for HSCs as described above, fixed and permeabilized using
the BrdU flow kit (BD Biosciences). These cells were then stained
with anti-BrdU-FITC or anti-Ki-67-PerCp-Cy5.5 (Sola15) antibody
for 20 min. Cells stained for Ki-67 were further incubated with
DAPI for 30 min at room temperature as described (Yang et al.,
2008). Stained cells were analyzed by flow cytometry as described
above.
Serial transplantation and competitive repopulation
Wild-type or Smurf2-deficient mice (CD45.2+) were used as donors, and
congenic CD45.1+ mice (The Jackson Laboratory, Bar Harbor, ME) were
used as recipients. Eight- to ten-week-old recipient mice were lethally
irradiated (10 Gy) using a Cs137 irradiator 24 h before transplantation
and were treated with antibiotics (0.5 mg mL-1 neomycin and
100 U mL-1 polymyxin-B) in drinking water 24 h prior to exposure to
radiation until 1 month after transplantation. For serial transplantation,
5 9 106 donor BM cells were injected retro-orbitally into 8- to 10-week-
old lethally irradiated recipient mice. The transplantation cycle was
repeated every 2 months.
For competitive repopulation, 2-month-old WT CD45.1+/CD45.2+
mice were used as competitors. 1 9 106 donor BM cells were mixed
with 1 9 106 competitor BM cells and injected into 8- to 10-week-old
lethally irradiated recipient mice. The relative contributions from the
donors, competitors, or recipients in peripheral blood and BM of
reconstituted recipients were analyzed in flow cytometry using antibod-
ies to CD45.2-FITC (104) and CD45.1-PE-Cy7 (A20). Multilineage
reconstitution in peripheral blood was analyzed using antibodies to
B220-APC (RA3-6B2), CD3e-biotin (145-2C11), and CD11b-APC-Cy7
(M1/70, BD Biosciences). Antibodies were purchased from eBioscience
unless specified.
Quantitative RT–PCR
Total RNA was isolated from freshly collected BM or FACS-sorted LSK
cells using TRIzol (Invitrogen) and reverse-transcribed using Superscript II
reverse transcriptase (Invitrogen). Real-time PCR was carried out on MyiQ
iCycler using SYBR Green PCR kit (Bio-Rad, Hercules, CA). The following
primers were used: Smurf2 (5′-ATGAAGTCATTCCCCAGCAC-3′; 5′-
AACCGTGCTCGTCTCTCTTC-3′), p16 (5′-CGAACTCTTTCGGTCGTACC
C-3′; 5′-CGAATCTGCACCGTAGTTGAG-3′), p18 (5′-GGGGACCTAGAG
CAACTTACT-3′; 5′-AAATTGGGATTAGCACCTCTGAG-3′), p19 (5′- GCT
CTGGCTTTCGTGAACATG-3′; 5′-TCGAATCTGCACCGTAGTTGAG-3′),
and b-actin (5′-GCTCTTTTCCAGCCTTCCTT-3′, 5′-GTGCTAGGAG
CCAGAGCAGT-3′).
Statistical analysis
Data were presented as mean  SD. Two-tailed and unpaired
Student’s t-test was used for pairwise comparisons. Two-way ANOVA
was used for multiple comparisons. Kaplan–Meier survival curves were
plotted using GraphPad Prism 5.0, and statistical significance was
analyzed using the log-rank test. P < 0.05 was considered as statisti-
cally significant.
Acknowledgments
We thank Dr. Jie Song and Henry Huang for providing reagents, Erin
Cloherty for excellent technical assistance, and members of Zhang lab
for helpful discussions.
Smurf2 regulates stem cell aging, C. Ramkumar et al. 7
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Author contributions
C.R., R.M.G., and H.Z. designed the experiments and analyzed the data.
C.R., Y.K., S.E.T., and R.M.G. performed the experiments. C.R. and H.Z.
wrote the manuscript.
Funding
This work is supported by grants from the National Cancer Institute
(R01CA131210) and The Ellison Medical Foundation (AG-NS-0347-06)
to H.Z.
Conflict of interest
The authors declare no conflict of interest.
References
Adolfsson J, Borge OJ, Bryder D, Theilgaard-Monch K, Astrand-Grundstrom I,
Sitnicka E, Sasaki Y, Jacobsen SE (2001) Upregulation of Flt3 expression within
the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by
loss of self-renewal capacity. Immunity 15, 659–669.
Attema JL, Pronk CJ, Norddahl GL, Nygren JM, Bryder D (2009) Hematopoietic
stem cell ageing is uncoupled from p16 INK4A-mediated senescence. Oncogene
28, 2238–2243.
Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good
citizens, bad neighbors. Cell 120, 513–522.
Chambers SM, Goodell MA (2007) Hematopoietic stem cell aging: wrinkles in stem
cell potential. Stem Cell Rev. 3, 201–211.
Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007)
Aging hematopoietic stem cells decline in function and exhibit epigenetic
dysregulation. PLoS Biol. 5, e201.
Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT
(2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1.
Science 287, 1804–1808.
Cheshier SH, Morrison SJ, Liao X, Weissman IL (1999) In vivo proliferation and cell
cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl
Acad. Sci. USA 96, 3120–3125.
Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA,
Donehower LA (2007) The impact of altered p53 dosage on hematopoietic stem
cell dynamics during aging. Blood 109, 1736–1742.
Harrison DE (1980) Competitive repopulation: a new assay for long-term stem cell
functional capacity. Blood 55, 77–81.
Harrison DE, Astle CM (1982) Loss of stem cell repopulating ability upon
transplantation. Effects of donor age, cell number, and transplantation
procedure. J. Exp. Med. 156, 1767–1779.
Ikuta K, Weissman IL (1992) Evidence that hematopoietic stem cells express mouse
c-kit but do not depend on steel factor for their generation. Proc. Natl Acad. Sci.
USA 89, 1502–1506.
Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T,
DePinho RA, Sharpless NE, Scadden DT (2006) Stem-cell ageing modified by the
cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421–426.
Kong Y, Cui H, Zhang H (2011) Smurf2-mediated ubiquitination and degrada-
tion of Id1 regulates p16 expression during senescence. Aging Cell 10, 1038–
1046.
Krishnamurthy J, Torrice C, RamseyMR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE
(2004) Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299–
1307.
Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless
NE (2006) p16INK4a induces an age-dependent decline in islet regenerative
potential. Nature 443, 453–457.
Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD (2006) The
transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoi-
etic cells. Cancer Cell 9, 175–187.
Liang Y, Van Zant G, Szilvassy SJ (2005) Effects of aging on the homing and
engraftment of murine hematopoietic stem and progenitor cells. Blood 106,
1479–1487.
Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM,
Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD (2009) p53
regulates hematopoietic stem cell quiescence. Cell Stem Cell 4, 37–48.
Mahmud N, Devine SM, Weller KP, Parmar S, Sturgeon C, Nelson MC, Hewett T,
Hoffman R (2001) The relative quiescence of hematopoietic stem cells in
nonhuman primates. Blood 97, 3061–3068.
Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A,
Thorner M, Scrable H (2004) Modulation of mammalian life span by the short
isoform of p53. Genes Dev. 18, 306–319.
Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless
NE, Morrison SJ (2006) Increasing p16INK4a expression decreases forebrain
progenitors and neurogenesis during ageing. Nature 443, 448–452.
Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL (1996) The aging
of hematopoietic stem cells. Nat. Med. 2, 1011–1016.
Ogden DA, Mickliem HS (1976) The fate of serially transplanted bone marrow cell
populations from young and old donors. Transplantation 22, 287–293.
Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Miura Y, Suda T (1992) In vivo
and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic
cells. Blood 80, 3044–3050.
Orford KW, Scadden DT (2008) Deconstructing stem cell self-renewal: genetic
insights into cell-cycle regulation. Nat. Rev. Genet. 9, 115–128.
Osawa M, Nakamura K, Nishi N, Takahasi N, Tokuomoto Y, Inoue H, Nakauchi H
(1996) In vivo self-renewal of c-Kit+ Sca-1 + Lin(low/-) hemopoietic stem cells.
J. Immunol. 156, 3207–3214.
Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL,
Weissman IL (2011) Human bone marrow hematopoietic stem cells are increased
in frequency and myeloid-biased with age. Proc. Natl Acad. Sci. USA 108,
20012–20017.
Papathanasiou P, Attema JL, Karsunky H, Xu J, Smale ST, Weissman IL (2009)
Evaluation of the long-term reconstituting subset of hematopoietic stem cells
with CD150. Stem Cells 27, 2498–2508.
Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL (2005) Global
analysis of proliferation and cell cycle gene expression in the regulation of
hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599–1611.
Ramkumar C, Kong Y, Cui H, Hao S, Jones SN, Gerstein RM, Zhang H (2012)
Smurf2 regulates the senescence response and suppresses tumorigenesis in
mice. Cancer Res. 72, 2714–2719.
Ramkumar C, Cui H, Kong Y, Jones SN, Gerstein RM, Zhang H (2013) Smurf2
suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitina-
tion and degradation of YY1. Nat. Commun. 4, 2598–2610.
Rando TA (2006) Stem cells, ageing and the quest for immortality. Nature 441,
1080–1086.
Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K,
Jansen-Durr P, Wlaschek M (2006) p16INK4A is a robust in vivo biomarker of
cellular aging in human skin. Aging Cell 5, 379–389.
Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL (2005)
Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl Acad.
Sci. USA 102, 9194–9199.
Rossi DJ, Jamieson CH, Weissman IL (2008) Stems cells and the pathways to aging
and cancer. Cell 132, 681–696.
Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer.
J. Clin. Invest. 113, 160–168.
Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow
old. Nat. Rev. Mol. Cell Biol. 8, 703–713.
Sudo K, Ema H, Morita Y, Nakauchi H (2000) Age-associated characteristics of
murine hematopoietic stem cells. J. Exp. Med. 192, 1273–1280.
TeKippe M, Harrison DE, Chen J (2003) Expansion of hematopoietic stem cell
phenotype and activity in Trp53-null mice. Exp. Hematol. 31, 521–527.
Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X,
Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A,
Donehower LA (2002) p53 mutant mice that display early ageing-associated
phenotypes. Nature 415, 45–53.
Van ZantG, LiangY (2003) The role of stemcells in aging. Exp.Hematol.31, 659–672.
Wilson A, Oser GM, Jaworski M, Blanco-Bose WE, Laurenti E, Adolphe C, Essers
MA, Macdonald HR, Trumpp A (2007) Dormant and self-renewing hematopoi-
etic stem cells and their niches. Ann. N. Y. Acad. Sci. 1106, 64–75.
Yang Q, Kardava L, St Leger A, Martincic K, Varnum-Finney B, Bernstein ID,
Milcarek C, Borghesi L (2008) E47 controls the developmental integrity and cell
cycle quiescence of multipotential hematopoietic progenitors. J. Immunol. 181,
5885–5894.
Smurf2 regulates stem cell aging, C. Ramkumar et al.8
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Yuan Y, Shen H, Franklin DS, Scadden DT, Cheng T (2004) In vivo self-renewing
divisions of haematopoietic stem cells are increased in the absence of the early
G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6, 436–442.
Zhang H, Cohen SN (2004) Smurf2 up-regulation activates telomere-dependent
senescence. Genes Dev. 18, 3028–3040.
Supporting Information
Additional Supporting Information may be found in the online version of this
article at the publisher’s web-site.
Fig. S1 Smurf2 expression in sorted HSCs, MPPs, CLPs, and body weights of
wild-type and Smurf2-deficient mice.
Fig. S2 Average numbers of progenitor populations in bone marrows of wild-
type and Smurf2-deficient mice at young and old ages.
Fig. S3 Complete blood count analysis of peripheral blood in wild-type and
Smurf2-deficient mice at young and old ages.
Fig. S4 Cell proliferation of bone marrow cells and progenitor populations in
wild-type and Smurf2-deficient mice.
Fig. S5 Donor contributions to bone marrow and complete blood count
analysis of peripheral blood in recipient mice during serial transplantation.
Fig. S6 Survival of recipient mice receiving bone marrow from 2-month-old
Smurf2-deficient donors in the 5th transplantation cycle.
Smurf2 regulates stem cell aging, C. Ramkumar et al. 9
ª 2014 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
